Overview

Evaluation of Etomidate on Adrenal Function in Trauma Patients

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
Trauma patients are at increased risk for adrenal function insufficiency. A commonly used agent for rapid sequence intubation (RSI) is known to decrease adrenal function. We want to determine the incidence of adrenocortical insufficiency and its significance during the first 24 hours of resuscitation following RSI in trauma patients.
Phase:
N/A
Details
Lead Sponsor:
University of Tennessee
Treatments:
Etomidate
Fentanyl
Midazolam
Succinylcholine